Navigation Links
DATATRAK International, Inc. to Release 2009 Second Quarter and First-Half Operating Results on August 17, 2009
Date:8/13/2009

ZGF0YXRyYWtu/SIG=10tne1bu0/**http%3A/www.datatrak.net/" target="_new">www.datatrak.net.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors (including those specified below) which are difficult to predict and, in many instances, are beyond the control of the Company. Factors that may cause actual results to differ materially from those in the forward-looking statements include the limited operating history on which the Company's performance can be evaluated; the ability of the Company to continue to enhance its software products to meet customer and market needs; fluctuations in the Company's quarterly results; the viability of the Company's business strategy and its early stage of development; the timing of clinical trial sponsor decisions to conduct new clinical trials or cancel or delay ongoing trials; the Company's dependence on major customers; government regulation associated with clinical trials and the approval of new drugs; the ability of the Company to compete in the emerging EDC market; losses that potentially could be incurred from breaches of contracts or loss of customer data; the inability to protect intellectual property rights or the infringement upon other's intellectual property rights; the costs associated with maintaining and/or developing two product suites; and general economic conditions such as the rate of employment, inflation, interest rates and the condition of capital markets. This list of factors is not all-inclusive. In addition, the Company's success depends on the outcome of various strategic initiatives it has undertaken, all of which are based on assumptions made by the
'/>"/>

SOURCE DATATRAK International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. DATATRAK International, Inc. Forms Strategic Partnership with Inclinix, Inc.
2. BioEnergy International, LLC Announces Formation of Myriant Technologies LLC
3. Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program
4. Rodobo International, Inc. Reports Q2 and First Half of 2009
5. Cryo-Cell International, Inc. Reports First Quarter 2009 Results
6. MINRAD International, Inc. Announces Reduction in Workforce
7. Medizone International, Inc. Announces Establishment of Canadian Foundation for Global Health
8. Sangui Biotech International, Inc., Reports Sales Decrease, Continued Losses
9. Cryo-Cell International, Inc. Reports Third Quarter 2008 Results
10. China Yingxia International, Inc. Announces $2 Million Share Repurchase Program
11. BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... In contrast to traditional LED lights where the spectrum ... proprietary LED technology to incorporate their spectra in a ... critical in low proximity installations. The Valoya L-series offers ... which is up to four times longer than commonly ... was clearly higher when compared to traditional fluorescent or ...
(Date:12/19/2014)... San Diego, CA (PRWEB) December 18, 2014 ... announces a limited time special on Sartorius Biohit ... 1 Free on mLINE pipettes, Picus Electronic Pipette Trade-in ... recommended by Health and Safety officers around the world. ... repetitive manual pipetting. Other features include:, , ...
(Date:12/19/2014)... Egenix, Inc. is pleased to announce that Lionel Goldfrank ... succeed Donald Fresne ; Mr. Fresne has also resigned ... of the Board.  In recognition of the many contributions and ... twenty years, the Board designated Mr. Fresne as Chairman Emeritus. ... Search Committee to find a suitable replacement with Biotech industry ...
(Date:12/19/2014)... Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... pain, announced the results of its annual general meeting ... transformational year in Relmada,s history and it set the ... Sergio Traversa , chief executive officer of Relmada. ... financial, human resource and clinical development objectives that position ...
Breaking Biology Technology:Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials 2Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2
... LA JOLLA, Calif., Nov. 25 TorreyPines Therapeutics, Inc.,(Nasdaq: ... purchased from Eli Lilly & Company,a reduction in certain ... on,net sales of TorreyPines, clinical-stage compounds NGX426 and tezampanel,should ... tier,royalty rate will be reduced three percentage points and ...
... 25 t2cure, a,biopharmaceutical company developing regenerative medicine ... that it has acquired a family of,patents and ... Frankfurt University. , ... for the rapid characterization,of the potency of bone ...
... FRANCISCO, Calif., Nov. 25 Sunesis Pharmaceuticals, Inc. (Nasdaq: ... of new oncology therapeutics for the treatment of solid and hematologic ... following upcoming conferences during the month of December: , ... Annual Health Care Conference , The New ...
Cached Biology Technology:TorreyPines Therapeutics Enters into Agreement to Reduce Royalty Rates and Delay Clinical Milestone Payments Due to Eli Lilly for NGX426 and Tezampanel 2t2cure Acquires Patent Family on In Vitro Potency Testing of Stem Cells for Cardiovascular Application 2Sunesis to Present at Upcoming Conferences 2
(Date:12/10/2014)... , Dec. 08, 2014 Research and ... the addition of the "Biometrics Market in ... http://photos.prnewswire.com/prnh/20130307/600769 ... projects such as rural banking and upgradation of ... trends witnessed in the market. Besides the aforementioned ...
(Date:12/5/2014)... Utah , Dec. 4, 2014  Tute Genomics, ... raised $2.3 million in Series A1 funding led by ... investors also participated in the investment round. ... the healthcare community adopts next-generation sequencing and seeks new ... said Reid Robison , MD MBA, and CEO ...
(Date:12/3/2014)... , Dec. 2, 2014 As part ... readers, Inception Technologies is pleased to announce the release ... for customers to collect the workforce data that they ... that have been left by existing readers. Many such ... interface, connectivity and modern technology. Older models force users ...
Breaking Biology News(10 mins):Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Inception Technologies to Release New Biometric Reader 2
... If world leaders do not immediately engage in a race ... ecosystems will not survive the global warming and acidification predicted ... group of marine scientists from around the world in a ... 13., "It,s vital that the public understands that the lack ...
... at Stevens Institute of Technology, won first place at ... in November 2007. Freed was the first competitor from ... poster, Impedance Mammography, was based on a project she ... April 2007, the New Jersey Regional ISPE Poster Contest ...
... 20, 2007) -- At its core, healthy neurological function hinges ... the synapse. Figuring out how the synapse traffics this ... understanding the function of the healthy and diseased brain. ... Medical College in New York City has spotted a crucial ...
Cached Biology News:Major study concludes that global warming is killing off coral 2Katherine Freed wins first place at the International ISPE Undergraduate Poster Contest 2A key enzyme helps keep the synapse on track 2A key enzyme helps keep the synapse on track 3
... Cassettes facilitate the hybridization of DNA or ... 25mm x 75mm glass slides. The proprietary ... correct for poor flatness, as is often ... low volume chamber (67uL analytical cavity volume) ...
... This reagent is formulated specifically for Alkaline ... high levels of activity for both the ... at final dilution. This product has ... providing the customer a longer shelf life, ...
... Lambda Free Light Chain ... of human immunoglobulin. Specificity: ... epitope of lambda chain. Reacts with ... lambda chains but not with lambda ...
... The SDSaway reagent is a valuable tool ... The presence of SDS in biological ... tightly bound SDS-protein complex, inhibits enzymatic activity ... presents as a contaminant in mass spectrometry ...
Biology Products: